Illumina supports Norway's pioneering precision medicine study
Illumina said it supports a study in Norway to assess the efficacy of blood-based comprehensive genomic profiling in cancer therapy selection testing.
Source: scienceboard.net
Stay updated with breaking news from Umor Matching. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Illumina said it supports a study in Norway to assess the efficacy of blood-based comprehensive genomic profiling in cancer therapy selection testing.